We talk to Keren Leshem, Chief Executive Officer, OCON Healthcare about how she transformed OCON's business strategy, the importance of educating women on their health and options, and how being mentored as well as acting as a mentor has shaped her career and outlook.

This week, we reflect on the highlights in pharma throughout August, covering the latest in COVID-19 therapy developments, the most notable mergers and acquisitions, marketing highlights, and the latest in research and development.

This week, we speak with Dr Jerome Kim, Director General, International Vaccine Institute, about vaccines. The conversation covers the nuances of the vaccine development process, the pharmaceutical industry's role in addressing vaccine hesitancy and refusal, and equitable distribution. He also shares his experience of working within the US military.

This week, we talk to Dirk Kosche, President, Established Markets, Astellas Pharma Europe Ltd, about turning innovation into value for patients, the role of the pharmaceutical industry in addressing health inequities, and his appreciation for the Japanese work culture.

This week, we reflect on the highlights in pharma throughout July, covering the latest in COVID-19 developments, the most prestigious mergers and acquisitions, marketing standouts, and the latest in research and development.

This week, we speak with Jennifer Cain Birkmose, Senior Pharmaceutical Leader in Market Access, Patient Access, and Patient Advocacy. She explores the idea of co-designing clinical trials and treatment with patients, discusses the concept behind reverse mentoring, and reveals how the rules of improvisation help her when leading teams.

This week, we speak with Alexey Cherchago, Head of Sales Excellence Europe, Sandoz, about leadership, how the role of the medical sales representative has evolved, and what the 'new normal' will look like within pharma's commercial teams.

This week, we reflect on the highlights in pharma throughout June, covering the latest in COVID-19 therapy developments, the most notable mergers and acquisitions, marketing highlights, and the latest in research and development.